Martinez Eliana C, Kofidis Theo
Department of Surgery, National University of Singapore, 5 Lower Kent Ridge Road, level 2, 119074, Singapore.
Expert Rev Cardiovasc Ther. 2009 Aug;7(8):921-8. doi: 10.1586/erc.09.81.
There has been an intense and competitive quest to manufacture bioartificial heart muscle in the last decade. Numerous biocompatible scaffolds and scaffold-free systems, enriched with various cell types, have been used to fabricate 3D grafts for myocardial repair. In spite of the impressive achievements in the myocardial tissue-engineering field, many issues remain to be addressed before clinical application of this strategy becomes feasible. This is largely due to the uniqueness of the heart's structure and function. This review provides a survey upon the reported strategies, and indicates caveats and perspectives in the field of myocardial tissue engineering.
在过去十年中,人们一直在激烈竞争地寻求制造生物人工心肌。许多富含各种细胞类型的生物相容性支架和无支架系统已被用于制造用于心肌修复的三维移植物。尽管心肌组织工程领域取得了令人瞩目的成就,但在该策略临床应用可行之前,仍有许多问题有待解决。这主要是由于心脏结构和功能的独特性。本综述对已报道的策略进行了概述,并指出了心肌组织工程领域的注意事项和前景。